Zongmin Zhang

ORCID: 0000-0002-6409-4603
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Thyroid Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Thyroid and Parathyroid Surgery
  • Cancer Diagnosis and Treatment
  • Head and Neck Surgical Oncology
  • Head and Neck Anomalies
  • S100 Proteins and Annexins
  • Radiopharmaceutical Chemistry and Applications
  • Lung Cancer Treatments and Mutations
  • Cancer-related Molecular Pathways
  • Reconstructive Surgery and Microvascular Techniques
  • Structural Load-Bearing Analysis
  • Structural Analysis and Optimization
  • Cancer Research and Treatments
  • Peptidase Inhibition and Analysis
  • Cleft Lip and Palate Research
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Parathyroid Disorders and Treatments
  • Tracheal and airway disorders
  • Metastasis and carcinoma case studies
  • Testicular diseases and treatments
  • Oral and Maxillofacial Pathology
  • Seismic Performance and Analysis
  • Ear and Head Tumors

Chinese Academy of Medical Sciences & Peking Union Medical College
2012-2024

Hong Kong University of Science and Technology
2024

University of Hong Kong
2024

North China University of Water Resources and Electric Power
2019-2023

Beijing University of Technology
2019-2020

Beijing University of Civil Engineering and Architecture
2019

Peking Union Medical College Hospital
2004-2017

Air Force Medical University
2015

Academia Sinica
2010

Academy of Medical Sciences
2010

<div>Abstract<p>Medullary thyroid carcinoma (MTC) can only be cured through the excision of all metastatic lesions, but current clinical practice fails to localize disease in 29% 60% patients. Previously, we developed a fibroblast activation protein inhibitor (FAPI)-based covalent targeted radioligand (CTR) for improved detection sensitivity and accuracy. In this first-in-class trial, head-to-head compared [<sup>68</sup>Ga]Ga-CTR-FAPI PET-CT...

10.1158/2159-8290.c.7662945 preprint EN 2025-02-07

The National Comprehensive Cancer Network (NCCN) guidelines recommend completion thyroidectomy for patients with multifocal papillary thyroid carcinoma (PTC) diagnosed by paraffin pathology after lobectomy. However, studies the influence of surgical range on prognosis unilateral are scarce. We analyzed clinicopathological characteristics and long-term outcomes PTC to identify risk factors recurrence disease-related death. clinical pathological data 123 cases lesions in lobe were...

10.1097/md.0000000000007461 article EN cc-by-nc Medicine 2017-07-01

Abstract Medullary thyroid carcinoma (MTC) can only be cured through the excision of all metastatic lesions, but current clinical practice fails to localize disease in 29% 60% patients. Previously, we developed a fibroblast activation protein inhibitor (FAPI)-based covalent targeted radioligand (CTR) for improved detection sensitivity and accuracy. In this first-in-class trial, head-to-head compared [68Ga]Ga-CTR-FAPI PET-CT [18F]fluorodeoxyglucose ([18F]FDG) 50 patients with MTC. The primary...

10.1158/2159-8290.cd-24-0897 article EN cc-by-nc-nd Cancer Discovery 2024-10-29

Background: B7-H3, also known as CD276, an important immune checkpoint member of the B7-CD28 family, is confirmed a promising target after PD-L1 in clinical trials. Although overexpression B7-H3 has been associated with invasive metastatic potential and poor prognosis multiple types cancer, nothing regarding expression profiles papillary thyroid carcinoma (PTC). In this study, we carried out large-scale analysis PTC patients evaluated significance B7-H3. Methods: total, data from 1,210...

10.3389/fcell.2022.819236 article EN cc-by Frontiers in Cell and Developmental Biology 2022-04-12
Coming Soon ...